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Introduction: Ventral mesh rectopexy (VMR) is a recognized treatment for posterior
compartment pelvic organ prolapse (POP). The aim of this review is to provide a synopsis
of the evidence for biological mesh use in VMR, the most widely recognized surgical
technique for posterior compartment POP.
Methods: A systematic search of PubMed was conducted using the search terms
“VMR,” “ventral mesh rectopexy,” or “mesh rectopexy.” Six studies were identified.
Results: About 268/324 patients underwent ventral rectopexy using biological mesh with
a further 6 patients having a combination of synthetic and biological mesh. Recurrence
was reported in 20 patients; however, 6 were from studies where data on biological mesh
could not be extracted. There are no RCTs in VMR surgery and no studies have directly
compared types of biological mesh. Cross-linked porcine dermal collagen is the most
commonly used mesh and has not been associated with mesh erosion, infection, or
fistulation in this review. The level of evidence available on the use of biological mesh
in VMR is of low quality (level 4).
Conclusion: Ventral mesh rectopexy has become prevalent for posterior compartment
POP. The evidence base for its implementation is not strong and the quality of evidence
to inform choice of mesh is poor.
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INTRODUCTION
Ventral mesh rectopexy (VMR) is a recognized treatment for posterior compartment pelvic organ
prolapse (POP). It is believed to address functional bowel symptoms by providing suspensory
support to the prolapsing organ (in this case the rectum the vaginal vault) and avoiding the auto-
nomic denervation that results in de novo symptomatology. Consequently, it improves obstructive
defaecatory symptoms as well as symptoms of incontinence (1–4) without initiating significant
new onset constipation (1, 5). VMR comprises dissection of the rectovaginal septum from above
to the level of the pelvic floor. This is followed by fixation of a synthetic or biological prosthesis
to the anterior wall of the rectum and proximally to the sacral promontory (Figures 1 and 2).
The vaginal vault may also be fixed to the mesh to provide support and help obliterate the deep
rectovaginal pouch. VMR has rapidly established itself in Europe as the procedure of choice for
posterior compartment POP in spite of a limited evidence base.
A variety of synthetic meshes have been used for a wide range of POP surgery but there have
been reports of high rates of pelvis sepsis, as well as concerns regarding mesh erosion, dyspareunia,
fistulation. and stricturing (6–8). The Food and Drug Administration (FDA) issued a warning in
2011 that, “serious complications associated with surgical mesh for transvaginal repair of POP are
not rare” (9). It is not clear to what extent this warning is relevant to POP surgery carried out via
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FIGURE 1 | Placement of mesh anterior to rectum and suturing to the
anterior wall of the rectum suture to vaginal vault.
FIGURE 2 | Tacking of mesh to sacral promontory. Photographs by kind
permission of Mr. Mark Mercer-Jones, Consultant Colorectal Surgeon,
Gateshead, UK.
abdominal approaches. Nevertheless, since it has been postulated
that biological mesh may cause fewer complications in compari-
son to synthetic mesh in certain high-risk circumstances (10–12).
This has led to an increase in the popularity of biological mesh use
for POP surgery. The aim of this review is to provide a synopsis
of the evidence for biological mesh use in VMR, the most widely
recognized surgical technique for posterior compartment POP.
METHODS
A systematic search of PubMed was conducted using the search
terms “VMR,” “ventral mesh rectopexy,” or “mesh rectopexy.”
Titles, abstracts, and finally full texts were analyzed for studies
reporting on the use of biological mesh in rectopexy. Inclusion
criteria were studies that described a ventral rectopexy using a bio-
logical mesh in either an open or laparoscopic technique. Studies
were excluded if only synthetic mesh was used or if there was no
mention of a mesh. Furthermore, studies on patients under the
age of 18 were excluded as well as non-English language studies,
technical tips, or duplicates series from the same research group.
Overall, the search yielded six studies for analysis after the exclu-
sion of review articles. The study characteristics are presented
(Table 1).
RESULTS
In the 6 case series, there was a total of 324 patients. Of these,
268 patients underwent ventral rectopexy using biological mesh
with a further 6 patients having a combination of synthetic mesh
and biological mesh. Overall, 155 patients underwent VMR using
additionally cross-linked porcine dermal collagen (Permacol™ or
Pelvicol™) and 89 using porcine intestinal submucosa (Surgisis©).
Recurrence was reported in 20 patients; however, 6 of these were
from studieswhere data on biologicalmesh could not be extracted.
One study did not report recurrence. Complications are outlined
(Table 1).
There are no randomized controlled trials in VMR surgery
generally and no studies have directly compared types of bio-
logical mesh, e.g., cross-linked vs. non-cross-linked. Cross-linked
porcine dermal collagen is themost commonly usedmesh and has
not been associated with mesh erosion, infection, or fistulation in
this current review. The level of evidence available on the use of
biological mesh in VMR is of low quality (level 4) (13).
DISCUSSION/SUMMARY
Ventral mesh rectopexy has become established as the current
procedure of choice for posterior compartment POP without a
high quality evidence base in support of its adoption and therefore
this has consequently been called into question (14). In light of
the limited evidence base for VMR generally, it is perhaps of no
surprise that the level of evidence for any specific mesh type,
either synthetic or biological, is level 4. The expert consensus
assumes that VMR is the optimal treatment paradigm in many
circumstances (15). This may well turn out to be the case, but as
yet the evidence basis is lacking and recommendations regarding
any specific type of mesh are at best grade C (16).
All the included studies are retrospective, often with short
follow-up, have small numbers of patients and are usually derived
from single institutions. The applicability of the findings to awider
population is uncertain. There is one comparative case series with
29 patients undergoing laparoscopic VMRusing a biologicalmesh
and 29 patients matched for age and surgical indication, undergo-
ing laparoscopic VMR using a synthetic mesh (17). However, it
did not meet the inclusion criteria for the review as it was a subset
analysis of data that has already been presented and discussed
and was therefore excluded. Furthermore, the other key limitation
for most of the included studies is the variability of outcome
reporting and the lack of standardization of outcome measures.
Some studies report functional outcome scores for both con-
stipation and incontinence, e.g., Wexner/FISI, but these scoring
systems are not necessarily appropriate for obstructed defaecation
syndrome (ODS) or prolapse (18, 19). Disease-specific scoring
systems such as pelvic organ prolapse quantification system (POP-
Q) or the ODS score (20), and quality of life scores (e.g., SF-36
EQ-5D) may be more appropriate but, these have not been used
in any of the studies included in this review. Anorectal physiology
results are reported in some studies but correlation to anatomy,
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TABLE 1 | Study characteristics.
Author
(year)
Study
design
No. of
pts
Age Sex
(M:F)
Patient
characteristics
Material used Intervention Follow-up
(months)
Recurrence Complications LoE Notes
Enríquez-
Navascués
et al. (23)
Case
Series
57 Mean: 66
(19–81)
2:55 Total rectal prolapse: 11 Acellular porcine dermis
biological mesh (Pelvicol® ): 4
polypropylene macroporous
synthetic mesh (Ginemesh®,
Ethicon): 4 Combination: 3
Laparoscopic
rectopexy
25 (4–48)
Median
1 (Biologic) 1 reoperation 4
Rectoenteroceles with or
without descending
perineal syndrome: 4
Pelvicol®: 1 Combination: 3 Laparoscopic
rectopexy
-
Genitourinary pelvic organ
prolapse: 42
Pelvicol®: 36 Ginemesh®: 6 Pfannenstiel: 31
Laparoscopic: 11
9 (Biologic) 4 reoperation
Wahed
et al. (24)
Case
series
65 62
(31–89)
Median
3:62 Full thickness rectal
prolapse: 27 rectocele
with obstructive
defecation symptoms: 23
vaginal vault prolapse: 14
Fecal Incontinence: 1
Permacol™ Lap ventral
rectopexy
12 (1–29)
Median
2 Diarrhea: 2 4
UTI: 1
MI: 1
Sacral
osteomyelitis: 1
Intersphincteric
abscess: 1
Port site pain: 2
Strangulated port
site hernia: 1
Sileri
et al. (25)
Case
Series
34 59 (5–78)
median
0:34 Grade III or IV rectal
prolapse
Permacol™ Lap ventral
rectopexy
12months
(6–28)
mean
2 SBO: 1 4
UTI: 4
Subcutaneous
emphysema: 2
Sacral pain: 1
Hematoma: 1
Powar
et al. (26)
Case
series
120 62.5
years
(25–93)
0:120 Rectocele and internal
prolapse: 57
Full-thickness rectal
prolapse: 53
Surgisis Biodesign© : 89
Non-absorbable
polypropylene mesh: 31
Lap ventral
rectopexy
7.6months
median
3 (Bio
mesh)
Biologic group:
exacerbation of
chronic pain: 3
4 Cannot
separate
out pts
who had
Surgisis©
Lumbar discitis: 1
Other (solitary rectal
ulcer): 3
Pelvic pain: 2
Post-operative
hypotension: 1
Port site pain: 1
Vaginal discharge: 1
Nausea: 1
Urinary retention: 1
Atelectasis: 1
Evans
et al. (27)
Case
Series
36 (30
surgery)
44
(15–81)
median
5:31 SRUS: obstructive
defecation: 36
Clinical external rectal
prolapse: 4
External prolapse: 10
Internal rectal prolapse
Grade I: 2(6%),
Grade III: 6 (17%),
Grade IV: 14 (39%)
Polypropylene: 27
Permacol™: 3
Laparoscopic
ventral mesh
rectopexy: 29
STARR: 1
36months
(3–78)
Median
3 (unknown
whether
related to
Biological
mesh)
Vaginal stitch
sinus: 1
Wound infection: 1
Port site hernia: 1
Mortality: 1
4 Cannot
separate
out 3 pts
who had
Permacol™
Sileri
et al. (28)
Case
series
12 Mean age
63 years,
range
23–78)
0:12 Permacol™ Lap ventral
rectopexy
5months Not
reported
Port site
hematoma: 1
Subcutaneous
emphysema: 1
4
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recurrence or symptomology is not clearly defined. For those stud-
ies where VMR was used to treat ODS, post-operative defaecog-
raphy that supports long-term anatomical correction of prolapse
has not been reported.
Complications in the included studies are inconsistently
reported and standardized methods of reporting, such as
Clavien–Dindo have not been used (21). Two studies did notmeet
the inclusion criteria because they only addressed complications
pertaining to VMR. The first was a systematic review of reported
complications, which failed to demonstrate any difference in
complications between synthetic and biological mesh although
the follow-up was short (22). The second study has reported 50
patients referred for complications following VMR and has doc-
umented operative strategies and techniques. Although compli-
cations from both biological and synthetic meshes are discussed,
there is no denominator provided and therefore it is not possible
to ascertain the relative frequency of complications with each type
of mesh (6). It is interesting to note that the concerns raised by
the FDA have not been reported in the literature pertaining to
VMR to the same extent. Although most series have follow-ups of
short duration, in the transvaginal approach mesh complications
were mainly reported within 12months (8). This suggests that the
concerns relating to mesh placement via the transvaginal or other
perineal approaches may not be extrapolated to transabdominal
approaches.
CONCLUSION
Ventral mesh rectopexy has become prevalent for posterior com-
partment POP. The evidence base for its implementation is not
strong and the quality of evidence to inform choice of mesh
is poor.
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